Every few months, a founder calls us confused about a number. Usually it goes something like this: “Our last round priced us at ₹500 crore. Why is our ESOP pool being valued at ₹340 crore for the same date?”
It’s a fair question, and it comes up more often than you’d think — especially with startups that have raised a priced round in the last 12 months and are now issuing a fresh ESOP tranche. The short answer is that a fundraise valuation and an ESOP valuation are answering two completely different questions, for two completely different audiences, under two completely different sets of rules. In the US, this distinction is baked into the market through what’s commonly called a “409A valuation,” named after the section of the US tax code that governs it. India doesn’t have a direct equivalent, but it has something functionally similar — and founders who treat the two valuations as interchangeable usually end up either overpaying tax or under-pricing their ESOPs in a way that creates compliance headaches later.
What a fundraise valuation is actually measuring
When an investor prices a round, they’re not measuring the fair value of the company on a standalone basis. They’re pricing a negotiated transaction. The number reflects the investor’s conviction about future growth, the leverage each side had at the table, the structure of the preference shares, anti-dilution terms, board rights, and often, plain competitive pressure if multiple investors are chasing the same deal. A ₹500 crore post-money valuation might be driven as much by a term sheet war between two funds as by the company’s actual EBITDA trajectory.
This is why fundraise valuations tend to run ahead of intrinsic value, particularly for early and growth-stage companies. Preference shareholders are buying rights and protections that common shareholders — including your ESOP holders — simply don’t get. Liquidation preferences alone can mean that in a downside scenario, the preferred investor gets their capital back first, while common stock could be worth a fraction of the headline valuation, or even nothing.
What an ESOP valuation is actually measuring
An ESOP valuation, on the other hand, is meant to reflect the fair market value of the underlying equity that an employee would actually receive — ordinary common shares, with none of the preferential rights sitting on top. Under Indian tax law, this fair value matters in two very specific, very consequential ways.
First, under Rule 3(8)(iii) of the Income Tax Rules, the fair market value of shares on the date of exercise determines the perquisite value taxed in the employee’s hands as a salary component. If that FMV is inflated because it was borrowed straight from the last funding round, employees end up paying tax on notional value they haven’t actually realised — a real problem for employees exercising options ahead of an eventual exit that may take years.
Second, and just as important from the company’s side, is Section 56(2)(viib) of the Income Tax Act, which taxes the excess of issue price over fair market value as “income from other sources” when a closely held company issues shares. While ESOP allotments have some specific carve-outs and treatment nuances compared to a straight share issuance, the broader principle holds across corporate actions: FMV computed under the prescribed method — Rule 11UA, typically the Discounted Cash Flow method for an unquoted company backed by a merchant banker’s valuation report — is what the tax authorities will look to, not the round valuation quoted in your last press release.
Why the two numbers genuinely diverge
The core reason ESOP valuation and fundraise valuation aren’t the same number isn’t a technicality — it’s economic reality. A DCF-based fair value under Rule 11UA looks at projected free cash flows discounted back to present value, without layering in the preferential rights, control premiums, or strategic scarcity value that a specific investor priced in. Common stock is structurally junior to preference stock. A methodologically honest valuation has to price that difference, usually through an allocation model — an Option Pricing Model (OPM) or a probability-weighted expected return method — that splits total equity value across the different share classes based on their actual economic rights.
n practice, this usually means the per-share fair value used for ESOP purposes comes out lower than the round price per share, sometimes meaningfully so. We’ve seen cases where a fundraise implies a per-share price of ₹1,200, while the OPM-allocated common share value for the same date lands closer to ₹750–₹850. Both numbers are “correct” — they’re just answering different questions.
Where founders go wrong
The most common mistake we see is founders using the last round’s price per share directly to set the ESOP exercise price or to compute the FMV for tax purposes, either out of convenience or because a fundraise valuation report already exists and a separate ESOP valuation feels like an unnecessary cost. This creates two downstream problems: employees get taxed on inflated perquisite value at exercise, and the company’s own tax position on Section 56(2)(viib) exposure becomes harder to defend in a scrutiny assessment, since the department can reasonably ask why a formal Rule 11UA valuation wasn’t obtained. The second mistake is timing. Valuations are date-specific. A DCF-based fair value done for a Series B closing six months ago cannot simply be recycled for an ESOP grant happening today, particularly if the company has hit new milestones, burned significant runway, or seen a shift in its revenue multiple comparables.
What we recommend
Every time a company plans an ESOP grant or exercise event, get a fresh, independent fair market valuation under Rule 11UA specifically for that purpose, separate from any fundraise-linked valuation exercise. It costs a fraction of what a disputed tax notice or an unhappy cap table conversation with employees will cost later, and it gives both the company and its employees a defensible, methodology-backed number rather than a borrowed one.
If your startup is heading into a new ESOP tranche or preparing for a round, it’s worth getting the valuation conversation right before the numbers get locked into legal documents — not after.